留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中国女性乳腺癌发病相关危险因素:病例对照研究

徐雅莉 孙强 单广良 张瑾 廖海波 李世拥 姜军 邵志敏 蒋宏传 沈念春 石岳 尉承泽 张保宁 陈妍华 段学宁 李波

徐雅莉, 孙强, 单广良, 张瑾, 廖海波, 李世拥, 姜军, 邵志敏, 蒋宏传, 沈念春, 石岳, 尉承泽, 张保宁, 陈妍华, 段学宁, 李波. 中国女性乳腺癌发病相关危险因素:病例对照研究[J]. 协和医学杂志, 2011, 2(1): 7-14. doi: 10.3969/j.issn.1674-9081.2011.01.002
引用本文: 徐雅莉, 孙强, 单广良, 张瑾, 廖海波, 李世拥, 姜军, 邵志敏, 蒋宏传, 沈念春, 石岳, 尉承泽, 张保宁, 陈妍华, 段学宁, 李波. 中国女性乳腺癌发病相关危险因素:病例对照研究[J]. 协和医学杂志, 2011, 2(1): 7-14. doi: 10.3969/j.issn.1674-9081.2011.01.002
Ya-li XU, Qiang SUN, Guang-liang SHAN, Jin Zhang, Hai-bo Liao, Shi-yong Li, Jun JIANG, Zhi-min Shao, Hong-chuan JIANG, Nian-chun SHEN, Yue SHI, Cheng-ze YU, Bao-ning ZHANG, Yan-hua CHEN, Xue-ning DUAN, Bo LI. Risk Factors of Breast Cancer in China: A Case-Control Study[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(1): 7-14. doi: 10.3969/j.issn.1674-9081.2011.01.002
Citation: Ya-li XU, Qiang SUN, Guang-liang SHAN, Jin Zhang, Hai-bo Liao, Shi-yong Li, Jun JIANG, Zhi-min Shao, Hong-chuan JIANG, Nian-chun SHEN, Yue SHI, Cheng-ze YU, Bao-ning ZHANG, Yan-hua CHEN, Xue-ning DUAN, Bo LI. Risk Factors of Breast Cancer in China: A Case-Control Study[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(1): 7-14. doi: 10.3969/j.issn.1674-9081.2011.01.002

中国女性乳腺癌发病相关危险因素:病例对照研究

doi: 10.3969/j.issn.1674-9081.2011.01.002
基金项目: 

“十一五”国家科技支撑计划项目 2006BAI02A09

详细信息
    通讯作者:

    孙强 电话:010-88068140, E-mail:pumchsunqiang@126.com

  • 中图分类号: R737.9;R181.3+2;R181.2+3

Risk Factors of Breast Cancer in China: A Case-Control Study

More Information
  • 摘要:   目的  筛查中国女性乳腺癌发病相关危险因素, 为个体化评估中国女性乳腺癌发病危险性提供依据。  方法  在全国8个省市14家研究中心开展1:m配对病例对照研究, 采用调查问卷通过面对面交流收集乳腺癌发病相关危险因素信息。乳腺癌患者及其配对健康对照女性年龄、生活环境相匹配。应用1:m条件Logistic回归分析乳腺癌相关危险因素在病例组和对照组间的分布特点, 明确其与乳腺癌发病危险性的相关性。  结果  共纳入416例乳腺癌患者及1156例健康对照女性。中国女性乳腺癌发病相关危险因素包括体重指数(body mass index, BMI)≥24(OR=4.07, 95% CI:2.98~5.55), 乳腺良性病变活检史(OR=1.68, 95% CI:1.19~2.38), 初潮年龄≥14岁(OR=1.41, 95% CI:1.07~1.87), 生存压力大(1~4级, OR=2.15, 95% CI:1.26~3.66;5~9级, OR=3.48, 95% CI:2.03~5.95), 绝经(OR=2.22, 95% CI:1.50~3.28)(P < 0.05), 乳腺癌家族史(OR=1.72, 95% CI:1.15~2.58), 肿瘤家族史(乳腺癌除外)(OR=1.55, 95% CI:1.22~1.98)。口服避孕药(OR=1.59, 95% CI:0.83~3.05)亦增加乳腺癌发病危险性, 但差异未达到显著统计学意义(P>0.05)。  结论  中国女性乳腺癌发病相关危险因素包括BMI≥24、乳腺良性病变活检史、初潮年龄≥14岁、生存压力大、绝经、乳腺癌家族史及其他肿瘤家族史。本研究为个体化评估中国女性罹患乳腺癌危险性及广泛开展乳腺癌防治工作提供了依据。
  • 表  1  病例组与对照组基线特征及乳腺癌危险因素对比表

    表  2  条件配对多元Logistic回归分析乳腺癌危险因素

  • [1] Hoskins KF, Zwaagstra A, Ranz M.Validation of atool for identifying women athigh risk for here ditary breast cancer in population-basedscreening [J]. Cancer, 2006, 107: 1769-1776. doi:  10.1002/cncr.22202
    [2] Armstrong K, Eisen A, Weber WB.Assessing the risk of breast cancer[J].N Engl J Med, 2000, 342:564-571. doi:  10.1056/NEJM200002243420807
    [3] Domchek SM, Eisen A, Calzone K, et al.Application of breast cancer risk predictionmodels in clinical practice[J]. J Clin Oncol, 2003, 21:593-601. doi:  10.1200/JCO.2003.07.007
    [4] Freedman AN, Seminara D, Gail MH, et al.Cancer risk prediction models:a workshop on development, evaluation, and application[J].J Natl Cancer Inst, 2005, 97:715- 723. doi:  10.1093/jnci/dji128
    [5] van Asperen CJ, Jonker MA, Jacobi CE, et al.Risk estimation for healthy women from breast cancer families:new insights and new strategies[J].Cancer Epidemiol Biomarkers Prev, 2004, 13:87-93. doi:  10.1158/1055-9965.EPI-03-0090
    [6] Jacobi CE, deBock GH, Siegerink B, et al.Differences and similarities in breast cancer risk assessmentmodels in clinical practice:which model to choose? [J].Breast Cancer Res Treat, 2009, 115:381-390. doi:  10.1007/s10549-008-0070-x
    [7] Euhus DM.Understanding mathematical models for breast cancer risk assessment and counseling[J]. Breast J, 2001, 7:224-232. doi:  10.1046/j.1524-4741.2001.20012.x
    [8] Petram C, Ames RC, Sandhya P.Oral contraceptive use and the risk of breast cancer[J].Mayo Clin Proc, 2008, 83:86-91. doi:  10.4065/83.1.86
    [9] Sweeney C, Baumgartner KB, Byers T, et al.Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women[J].Cancer Causes Control, 2008, 19:391-401. doi:  10.1007/s10552-007-9098-1
    [10] Tjia J, Micco E, Armstrong K.Interest in breast cancer chemoprevention among older women[J].Breast Cancer Res Treat, 2008, 108:435-453. doi:  10.1007/s10549-007-9614-8
    [11] Euhus DM, Bu D, Ashfaq R, et al.Atypia and DNA methylation innipple duct lavage in relation to predicted breast cancer risk [J]. Cancer Epidemiol Biomarkers Prev, 2007, 16:1812-1821. doi:  10.1158/1055-9965.EPI-06-1034
    [12] Cazzaniga M, Severi G, Casadio C, et al.Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer[J].Cancer Epidemiol Biomarkers Prev, 2006, 15:1311-1315. doi:  10.1158/1055-9965.EPI-05-0810
    [13] Brinton LA, Sherman ME, Carreon JD, et al.Recent trends in breast cancer among younger women in the United States [J].J Natl Cancer Inst, 2008, 100:1643-1648. doi:  10.1093/jnci/djn344
    [14] Vachon CM, vanGils CH, Sellers TA, et al.Mammographic density, breast cancer risk and risk prediction[J].Breast Cancer Res, 2007, 9:217-225. doi:  10.1186/bcr1829
    [15] Boyd NF, Guo H, Martin LJ, et al.Mammographic density and the risk and detection of breast cancer[J].N Engl J Med, 2007, 356:227-236. doi:  10.1056/NEJMoa062790
    [16] Barlow WE, White E, Ballard-Barbash R, et al.Prospective breast cancer risk prediction model for women under going screen in gmammo graphy[J].J Natl Cancer Inst, 2006, 98:1204-1214. doi:  10.1093/jnci/djj331
    [17] Rockhill B, Spiegelman D, Byrne C, et al.Model of breast cancer risk prediction and implications for chemoprevention [J].J Natl Cancer Inst, 2001, 93:358-366. doi:  10.1093/jnci/93.5.358
    [18] Palomares MR, Machia JR, Lehman CD, et al.Mammographic density correlation with gailmodel breast cancer risk estimates and component risk factors[J].Cancer Epidemiol Biomarkers Prev, 2006, 15:1324-1330. doi:  10.1158/1055-9965.EPI-05-0689
    [19] Anderson WF, Matsuno RK, Sherman ME, et al.Estimating age-specific breast cancer risks:a descriptive tool to identify age interactions[J].Cancer Causes Control, 2007, 18: 439-447. doi:  10.1007/s10552-006-0092-9
    [20] Santen RJ, Boyd NF, Chlebowski RT, et al.Breast cancer prevention collaborative group.critical assessment of new risk factors for breast cancer:considerations for development of an improved risk prediction model[J].Endocr Relat Cancer, 2007, 14:169-187. doi:  10.1677/ERC-06-0045
    [21] Chen J, Pee D, Ayyagari R, et al.Projecting absolute invasive breast cancer risk in white women with a model that included mammographic density[J].J Natl Cancer Inst, 2006, 98:1215-1226. doi:  10.1093/jnci/djj332
    [22] Kelemen LE, Pankratz VS, Sellers TA, et al.Age-specific trends inmammographic density the minnesota breast cancer family study[J].Am J Epidemiol, 2008, 167:1027- 1036. doi:  10.1093/aje/kwn063
    [23] Huo D, Adebamowo CA, Ogundiran TO, et al.Parity and breast feeding are protective against breast cancer in Nigerian women[J].British J Cancer, 2008, 98:992-996. doi:  10.1038/sj.bjc.6604275
    [24] Suzuki S, Kojima M, Tokudome S, et al.Japan Collaborative Cohort Study Group.Effect of physical activity on breast cancer risk:findings of the Japan Coll aborative Cohort Study [J].Cancer Epidemiol Biomarkers Prev, 2008, 17:3396-3401. doi:  10.1158/1055-9965.EPI-08-0497
    [25] Pirie K, Beral V, Peto R, et al.Million women study coll aborators, passive smoking and breast cancer in never smokers:prospective study and meta-analysis[J].Int J Epidemiol, 2008, 37:1069-1079. doi:  10.1093/ije/dyn110
    [26] Cui X, Dai Q, Tseng M, et al.Dietary patterns and breast cancer risk in the Shanghai breast Cancer Study[J].Cancer Epidemiol Biomarkers Prev, 2007, 16:1443-1448. doi:  10.1158/1055-9965.EPI-07-0059
    [27] Mahoney MC, Bevers T, Linos E, et al.Opportunities and strategies for breast cancer prevention through risk reduction [J].CA Cancer J Clin, 2008, 58:347-371. doi:  10.3322/CA.2008.0016
    [28] Wellisch DK, Lindberg NM.A psychological profile of depressed and nondepressed women at high risk for breast cancer[J].Psychosomatics, 2001, 42:330-336. doi:  10.1176/appi.psy.42.4.330
    [29] Mouw T, Koster A, Wright ME, et al.Education and risk of cancer in a large cohort of men and women in the United States[J].PLo S One, 2008, 3:e3639. doi:  10.1371/journal.pone.0003639
    [30] Bremnes Y, Ursin G, Bjurstam N, et al.Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women:a cross-sectional study[J]. Breast Cancer Res, 2007, 9:R73. doi:  10.1186/bcr1782
    [31] Cardis E, Hall J, Tavtigian SV.Identification of women with an increased risk of developing radiation-induced breast cancer[J].Breast Cancer Research, 2007, 9:106. doi:  10.1186/bcr1733
    [32] Sant M, Francisci S, Capocaccia R, et al.Timetrends of breast cancer survival in Europe in relation to incidence and mortality[J].Int J Cancer, 2006, 119:2417-2422. doi:  10.1002/ijc.22160
    [33] Karliner LS, Napoles-Springer A, Kerlikowske K, et al. Missed opportunities:family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women[J].J Gen Intern Med, 2007, 22:308- 314. doi:  10.1007/s11606-006-0087-y
    [34] Gail MH, Costantino JP.Validating and improvingmodels for projecting the absolute risk of breast cancer[J].J Natl Cancer Inst, 2001, 93:334-335. doi:  10.1093/jnci/93.5.334
    [35] Gail MH, Benichou J.Epidemiology and biostatistics program of the national cancer institute[J].J Natl Cancer Inst, 1994, 86:573-575. doi:  10.1093/jnci/86.8.573
    [36] Kilfoy BA, Zhang Y, Shu XO, et al.Family history of malignancies and risk of breast cancer:prospective data from the Shanghai women's health study[J].Cancer Causes Control, 2008, 19:1139-1145. doi:  10.1007/s10552-008-9181-2
    [37] Rosenberg L, Zhang Y, Coogan PF, et al.Acase-control study of oral contraceptive use and incident breast cancer [J].Am J Epidemiol, 2009, 169:473-479. http://www.zhangqiaokeyan.com/academic-journal-foreign_other_thesis/020418410846.html
    [38] Oerlemans ME, van den Akker M, Schuurman AG, et al.A meta-analysis on depression and subsequent cancer risk[J]. Clin Pract Epidemol Ment Health, 2007, 3:329. http://archive.biomedcentral.com/1745-0179/3/29
    [39] Wakai K, Kojima M, Nishio K, et al.For the JACC Study Group.Psychological attitudes and risk of breast cancer in Japan:aprospective study[J].Cancer Causes Control, 2007, 18:259-267. doi:  10.1007/s10552-006-0111-x
    [40] Ozmen V, Ozcinar B, Karanlik H, et al.Breast cancer risk factors in Turkish women-a University hospital based nested case control study[J].World J Surg Oncol, 2009, 7:37. doi:  10.1186/1477-7819-7-37
    [41] Wu MH, Chou YC, Chou WY, et al.Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I(IGF-I) in breast cancer:Evidence from a case-control study[J].Int J Cancer, 2010, 126:508-514. doi:  10.1002/ijc.24722
    [42] Verkooijen HM, Rapiti E, Fioretta G, et al.Impact of a positive family history on diagnosis, management, and survival of breast cancer:different effects across socio-economic groups[J]. Cancer Causes Control, 2009, 20:1689- 1696. doi:  10.1007/s10552-009-9420-1
    [43] Folger SG, Marchbanks PA, McDonald JA, et al.Risk of breast cancer associated with short-term use of oral contraceptives[J].Cancer Causes Control, 2007, 18:189-198. doi:  10.1007/s10552-006-0086-7
    [44] Bondy ML, Newman LA.Assessing breast cancer risk:evolution of the Gail model[J].J Natl Cancer Inst, 2006, 98:1172-1173. doi:  10.1093/jnci/djj365
    [45] Adams-Campbell LL, Makambi KH, Palmer JR, et al.Diagnostic accuracy of the Gail model in the black women's health study[J].Breast J, 2007, 13:332-336. doi:  10.1111/j.1524-4741.2007.00439.x
    [46] Decarli A, Calza S, Masala G, et al.Gail model for prediction of absolute risk of invasive breast cancer:independent evaluation in the florence- European prospective investigation into cancer and nutrition cohort[J].J Natl Cancer Inst, 2006, 98:1686-1693. doi:  10.1093/jnci/djj463
    [47] Claus EB, Risch N, Thompson WD.Genetic analysis of breast cancer in the cancer and steroid hormone study[J]. Am J Hum Genet, 1991, 48:232-242. http://www.ncbi.nlm.nih.gov/pubmed/1990835
    [48] Fisher B, Costantino JP, Wickerham DL, et al.Tamoxifen for prevention of breast cancer:report of the national surgical adjuvant breast and bowel project P-1 study[J].J Natl Cancer Inst, 1998, 90:1371-1388. doi:  10.1093/jnci/90.18.1371
    [49] Jonker MA, Jacobi CE, Hoogendoorn WE, et al.Modeling familial clustered breast cancer using published data[J]. Cancer Epidemiol Biomarkers Prev, 2003, 12:1479-1485. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=9ff7fb32c963d6552fc3c37e035369b7
    [50] Antoniou AC, Pharoah PP, Smith P, et al.The BOADICEA model of genetic susceptibility to breast and ovarian cancer [J].Br J Cancer, 2004, 91:1580-1590. doi:  10.1038/sj.bjc.6602175
  • 加载中
表(2)
计量
  • 文章访问数:  254
  • HTML全文浏览量:  64
  • PDF下载量:  44
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-10-11
  • 刊出日期:  2011-01-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!